Given that several recommendations—especially those concerning HE-DMT safety profiles, fluid biomarkers such as serum NfL, and advanced MRI features—are based on emerging or rapidly evolving evidence, periodic re-evaluation of these consensus statements will be essential to ensure continued alignment with the latest clinical research. Here, NEFL is linked to hereditary elliptocytosis.